[Intermittent claudication: topical treatment with isosorbide dinitrate ointment. Preliminary results]. 1981

A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate

Following the casual observation reported by one anginal patient of ours, of improvement of its claudicatio intermittens with application of isosorbide dinitrate ointment directly on the leg suffering pain, we undertook a study to assess the possible use of the drug in peripheral vascular disease in a group of 10 patients suffering of a severe form of claudicatio intermittens. The effect of the drug was tested 1) by the subjective valuation of the patient itself 2) by treadmill stress tests performed at constant rate. In this case were used as reference parameters the distance walked without any symptoms and the maximal distance reached by each patient. The treadmill stress test was performed in basal condition and after longterm administration of isosorbide dinitrate ointment 100 mg three times a day for 30-45 days. In 5 patients the control test was repeated twice in different days to evaluate the reproducibility of the measure that resulted good, while other 5 patients performed the test one hour following the application of the drug in order to assess a possible acute effect of the drug that was not present in any patient. All the patients noted an improvement in their walking capacity but only after 15-20 days of treatment. In basal condition the distance walked without any symptoms by the patients was on the average m. 51 (+/- 52) and the maximal distance reached was m. 143 (+/- 111), while after the treatment were m. 151 (+/- 136) and m. 384 (+/- 203) with a difference highly significative (p less than 0.05 and p less than 0.01 respectively). From our data although preliminary, it is apparent that longterm local application of isosorbide dinitrate is effective in the treatment of patients with peripheral vascular disease and that the action of the drug seems to be related to a local effect.

UI MeSH Term Description Entries
D007383 Intermittent Claudication A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE. Claudication, Intermittent
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
January 1984, VASA. Zeitschrift fur Gefasskrankheiten,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
August 2000, International journal of colorectal disease,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
January 1983, Zeitschrift fur Kardiologie,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
December 1984, The Journal of the Association of Physicians of India,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
January 2003, Digestive surgery,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
July 1978, International journal of clinical pharmacology and biopharmacy,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
March 1961, The Journal-lancet,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
April 2018, American journal of medical genetics. Part A,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
June 1981, The Journal of the Association of Physicians of India,
A Biagini, and C Carpeggiani, and R Testa, and M G Mazzei, and C Michelassi, and A L'Abbate
December 2001, European journal of clinical pharmacology,
Copied contents to your clipboard!